Consulting Services
Compare Stocks
4 / 10Stock Comparison
CRAI vs ACN vs EPAM vs G
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
CRAI vs ACN vs EPAM vs G — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Consulting Services | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $899M | $112.19B | $5.51B | $5.85B |
| Revenue (TTM) | $771M | $72.11B | $5.56B | $5.16B |
| Net Income (TTM) | $48M | $7.68B | $387M | $570M |
| Gross Margin | 20.3% | 32.0% | 28.5% | 36.3% |
| Operating Margin | 9.8% | 14.8% | 9.9% | 14.9% |
| Forward P/E | 16.9x | 13.0x | 8.2x | 8.6x |
| Total Debt | $127M | $8.18B | $144M | $1.76B |
| Cash & Equiv. | $18M | $11.48B | $1.30B | $854M |
CRAI vs ACN vs EPAM vs G — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CRA International, … (CRAI) | 100 | 344.4 | +244.4% |
| Accenture plc (ACN) | 100 | 89.4 | -10.6% |
| EPAM Systems, Inc. (EPAM) | 100 | 45.3 | -54.7% |
| Genpact Limited (G) | 100 | 95.9 | -4.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRAI vs ACN vs EPAM vs G
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CRAI is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 9.3%, EPS growth 20.8%, 3Y rev CAGR 8.3%
- 5.5% 10Y total return vs ACN's 89.9%
- -20.7% vs ACN's -39.1%
ACN is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 14 yrs, beta 0.85, yield 3.2%
- 3.2% yield, 14-year raise streak, vs CRAI's 1.5%, (1 stock pays no dividend)
- 11.8% ROA vs CRAI's 7.6%, ROIC 26.8% vs 20.4%
EPAM is the clearest fit if your priority is growth.
- 15.4% revenue growth vs G's 6.6%
G carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.67, Low D/E 69.2%, current ratio 1.66x
- PEG 0.58 vs ACN's 1.44
- Beta 0.67, yield 1.9%, current ratio 1.66x
- Lower P/E (8.6x vs 13.0x), PEG 0.58 vs 1.44
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.4% revenue growth vs G's 6.6% | |
| Value | Lower P/E (8.6x vs 13.0x), PEG 0.58 vs 1.44 | |
| Quality / Margins | 11.0% margin vs CRAI's 6.2% | |
| Stability / Safety | Beta 0.67 vs EPAM's 1.21 | |
| Dividends | 3.2% yield, 14-year raise streak, vs CRAI's 1.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | -20.7% vs ACN's -39.1% | |
| Efficiency (ROA) | 11.8% ROA vs CRAI's 7.6%, ROIC 26.8% vs 20.4% |
CRAI vs ACN vs EPAM vs G — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CRAI vs ACN vs EPAM vs G — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
G leads in 2 of 6 categories
ACN leads 2 • EPAM leads 1 • CRAI leads 1
Explore the data ↓Income & Cash Flow (Last 12 Months)
G leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACN is the larger business by revenue, generating $72.1B annually — 93.6x CRAI's $771M. Profitability is closely matched — net margins range from 11.0% (G) to 6.2% (CRAI). On growth, CRAI holds the edge at +10.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $771M | $72.1B | $5.6B | $5.2B |
| EBITDAEarnings before interest/tax | $98M | $12.1B | $684M | $819M |
| Net IncomeAfter-tax profit | $48M | $7.7B | $387M | $570M |
| Free Cash FlowCash after capex | -$17M | $12.5B | $544M | $666M |
| Gross MarginGross profit ÷ Revenue | +20.3% | +32.0% | +28.5% | +36.3% |
| Operating MarginEBIT ÷ Revenue | +9.8% | +14.8% | +9.9% | +14.9% |
| Net MarginNet income ÷ Revenue | +6.2% | +10.7% | +7.0% | +11.0% |
| FCF MarginFCF ÷ Revenue | -2.2% | +17.3% | +9.8% | +12.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.5% | +8.3% | +7.6% | +6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -35.5% | +3.9% | +18.8% | +17.8% |
Valuation Metrics
EPAM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.0x trailing earnings, G trades at a 36% valuation discount to CRAI's 17.1x P/E. Adjusting for growth (PEG ratio), G offers better value at 0.74x vs EPAM's 4.18x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $899M | $112.2B | $5.5B | $5.9B |
| Enterprise ValueMkt cap + debt − cash | $1.0B | $108.9B | $4.4B | $6.8B |
| Trailing P/EPrice ÷ TTM EPS | 17.09x | 14.83x | 15.53x | 11.02x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.88x | 12.98x | 8.17x | 8.58x |
| PEG RatioP/E ÷ EPS growth rate | 0.79x | 1.64x | 4.18x | 0.74x |
| EV / EBITDAEnterprise value multiple | 10.36x | 8.60x | 6.74x | 7.91x |
| Price / SalesMarket cap ÷ Revenue | 1.20x | 1.61x | 1.01x | 1.15x |
| Price / BookPrice ÷ Book value/share | 4.37x | 3.53x | 1.60x | 2.39x |
| Price / FCFMarket cap ÷ FCF | 48.45x | 10.32x | 8.99x | 7.97x |
Profitability & Efficiency
ACN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ACN delivers a 23.9% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $11 for EPAM. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to G's 0.69x. On the Piotroski fundamental quality scale (0–9), EPAM scores 6/9 vs CRAI's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +23.6% | +23.9% | +10.7% | +22.4% |
| ROA (TTM)Return on assets | +7.6% | +11.8% | +8.1% | +10.3% |
| ROICReturn on invested capital | +20.4% | +26.8% | +15.5% | +17.2% |
| ROCEReturn on capital employed | +26.9% | +24.9% | +13.3% | +18.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.60x | 0.25x | 0.04x | 0.69x |
| Net DebtTotal debt minus cash | $109M | -$3.3B | -$1.2B | $911M |
| Cash & Equiv.Liquid assets | $18M | $11.5B | $1.3B | $854M |
| Total DebtShort + long-term debt | $127M | $8.2B | $144M | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | 14.51x | 40.67x | — | 16.55x |
Total Returns (Dividends Reinvested)
CRAI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRAI five years ago would be worth $17,152 today (with dividends reinvested), compared to $2,268 for EPAM. Over the past 12 months, CRAI leads with a -20.7% total return vs ACN's -39.1%. The 3-year compound annual growth rate (CAGR) favors CRAI at 15.5% vs EPAM's -23.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -30.3% | -29.4% | -47.9% | -24.5% |
| 1-Year ReturnPast 12 months | -20.7% | -39.1% | -34.4% | -29.0% |
| 3-Year ReturnCumulative with dividends | +54.1% | -25.5% | -55.0% | -7.4% |
| 5-Year ReturnCumulative with dividends | +71.5% | -29.5% | -77.3% | -20.8% |
| 10-Year ReturnCumulative with dividends | +550.5% | +89.9% | +48.8% | +42.5% |
| CAGR (3Y)Annualised 3-year return | +15.5% | -9.3% | -23.4% | -2.5% |
Risk & Volatility
G leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
G is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than EPAM's 1.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. G currently trades 68.6% from its 52-week high vs EPAM's 46.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.73x | 0.85x | 1.21x | 0.67x |
| 52-Week HighHighest price in past year | $227.29 | $325.71 | $222.53 | $50.24 |
| 52-Week LowLowest price in past year | $135.95 | $173.52 | $99.67 | $33.12 |
| % of 52W HighCurrent price vs 52-week peak | +61.2% | +55.3% | +46.9% | +68.6% |
| RSI (14)Momentum oscillator 0–100 | 41.1 | 33.5 | 22.5 | 35.4 |
| Avg Volume (50D)Average daily shares traded | 187K | 5.7M | 1.3M | 2.3M |
Analyst Outlook
ACN leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CRAI as "Buy", ACN as "Buy", EPAM as "Buy", G as "Hold". Consensus price targets imply 88.7% upside for EPAM (target: $197) vs 33.4% for G (target: $46). For income investors, ACN offers the higher dividend yield at 3.25% vs CRAI's 1.48%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $194.00 | $299.92 | $197.00 | $46.00 |
| # AnalystsCovering analysts | 1 | 53 | 37 | 39 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +3.2% | — | +1.9% |
| Dividend StreakConsecutive years of raises | 9 | 14 | — | 8 |
| Dividend / ShareAnnual DPS | $2.06 | $5.85 | — | $0.67 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.2% | +4.1% | 0.0% | +4.8% |
G leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). ACN leads in 2 (Profitability & Efficiency, Analyst Outlook).
CRAI vs ACN vs EPAM vs G: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CRAI or ACN or EPAM or G a better buy right now?
For growth investors, EPAM Systems, Inc.
(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus 6. 6% for Genpact Limited (G). Genpact Limited (G) offers the better valuation at 11. 0x trailing P/E (8. 6x forward), making it the more compelling value choice. Analysts rate CRA International, Inc. (CRAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRAI or ACN or EPAM or G?
On trailing P/E, Genpact Limited (G) is the cheapest at 11.
0x versus CRA International, Inc. at 17. 1x. On forward P/E, EPAM Systems, Inc. is actually cheaper at 8. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Genpact Limited wins at 0. 58x versus Accenture plc's 1. 44x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CRAI or ACN or EPAM or G?
Over the past 5 years, CRA International, Inc.
(CRAI) delivered a total return of +71. 5%, compared to -77. 3% for EPAM Systems, Inc. (EPAM). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus G's +42. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRAI or ACN or EPAM or G?
By beta (market sensitivity over 5 years), Genpact Limited (G) is the lower-risk stock at 0.
67β versus EPAM Systems, Inc. 's 1. 21β — meaning EPAM is approximately 81% more volatile than G relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 69% for Genpact Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — CRAI or ACN or EPAM or G?
By revenue growth (latest reported year), EPAM Systems, Inc.
(EPAM) is pulling ahead at 15. 4% versus 6. 6% for Genpact Limited (G). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -14. 3% for EPAM Systems, Inc.. Over a 3-year CAGR, CRAI leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRAI or ACN or EPAM or G?
Accenture plc (ACN) is the more profitable company, earning 11.
0% net margin versus 6. 9% for EPAM Systems, Inc. — meaning it keeps 11. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: G leads at 15. 0% versus 9. 6% for EPAM. At the gross margin level — before operating expenses — G leads at 35. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRAI or ACN or EPAM or G more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Genpact Limited (G) is the more undervalued stock at a PEG of 0. 58x versus Accenture plc's 1. 44x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, EPAM Systems, Inc. (EPAM) trades at 8. 2x forward P/E versus 16. 9x for CRA International, Inc. — 8. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EPAM: 88. 7% to $197. 00.
08Which pays a better dividend — CRAI or ACN or EPAM or G?
In this comparison, ACN (3.
2% yield), G (1. 9% yield), CRAI (1. 5% yield) pay a dividend. EPAM does not pay a meaningful dividend and should not be held primarily for income.
09Is CRAI or ACN or EPAM or G better for a retirement portfolio?
For long-horizon retirement investors, CRA International, Inc.
(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 5% yield, +550. 5% 10Y return). Both have compounded well over 10 years (CRAI: +550. 5%, EPAM: +48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRAI and ACN and EPAM and G?
These companies operate in different sectors (CRAI (Industrials) and ACN (Technology) and EPAM (Technology) and G (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CRAI is a small-cap deep-value stock; ACN is a mid-cap deep-value stock; EPAM is a small-cap high-growth stock; G is a small-cap deep-value stock. CRAI, ACN, G pay a dividend while EPAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.